sk&f-38393 has been researched along with Kidney Failure, Chronic in 5 studies
2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine: A selective D1 dopamine receptor agonist used primarily as a research tool.
1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol : A benzazepine that is 2,3,4,5-tetrahydro-3-benzazepine bearing a phenyl substituent at position 1 and two hydroxy substituents at positions 7 and 8.
SKF 38393 : A racemate comprising equimolar amounts of (R)- and (S)-SKF 38393
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "These results show that for advanced chronic renal failure, fenoldopam has diuretic and natriuretic properties that could be of clinical relevance." | 1.28 | Diuretic and natriuretic properties of fenoldopam in chronic renal failure. ( Alcázar, JM; Alvarez, C; Andrés, A; García-Robles, R; Martínez, J; Oliet, A; Rodicio, JL; Ruilope, LM; Sancho, J, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robles, RG | 1 |
| Villa, E | 1 |
| Andres, A | 2 |
| Martinez, J | 2 |
| Ruilope, LM | 2 |
| Sancho, JM | 1 |
| Girbes, AR | 1 |
| van Veldhuisen, DJ | 1 |
| Smit, AJ | 2 |
| de Fijter, CW | 1 |
| Comans, EF | 1 |
| de Vries, PM | 1 |
| Oe, PL | 1 |
| Roos, JC | 1 |
| Streurman, O | 1 |
| Donker, AJ | 1 |
| Brooks, DP | 1 |
| Goldstein, R | 1 |
| Koster, PF | 1 |
| DePalma, PD | 1 |
| DiCristo, M | 1 |
| Karpinski, K | 1 |
| Hyneck, M | 1 |
| García-Robles, R | 1 |
| Alcázar, JM | 1 |
| Alvarez, C | 1 |
| Oliet, A | 1 |
| Sancho, J | 1 |
| Rodicio, JL | 1 |
5 other studies available for sk&f-38393 and Kidney Failure, Chronic
| Article | Year |
|---|---|
Natriuretic effects of dopamine agonist drugs in models of reduced renal mass.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Adult; Aged; Animals; Blood Pressure; Di | 1993 |
Dopamine agonists, a new perspective in cardiovascular therapy?
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Deoxyepinephrine; Dopamine Agents; Fenol | 1991 |
The effect of fenoldopam on renal haemodynamics and natriuresis in chronic renal failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Adult; Aged; Aldos | 1990 |
Effect of fenoldopam in dogs with spontaneous renal insufficiency.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Animals; Creatinin | 1990 |
Diuretic and natriuretic properties of fenoldopam in chronic renal failure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Blood Pressure; Diuresis; Dopamine Agent | 1989 |